NTT DATA Begins Offering Vitals Measurement Service with a Smartphone Camera for Commercial Use in Partnership with Canadian Firm NuraLogix Corporation
TOKYO, April 21, 2022 /PRNewswire/ -- NTT DATA, a global digital business and IT services leader, today announced that it began providing a "Vitals Measurement Service" on a commercial basis from January 2022 as a new function of its cloud-based health management solution Health Data Bank®. This system uses a smartphone camera to record video of a subject's face for...
Transcenta Successfully Passed the Audit of EU Qualified Person for the Manufacturing of TST001
SUZHOU, China, April 21, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that HJB (Hangzhou) Co., Ltd. (the "HJB"), a wholly-owned subsidiary of the Company, has successfully passed the audit of European Union qualified person on April 13, and an...
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
LAGUNA HILLS, Calif. and SHANGHAI and BOCHUM, Germany, April 21, 2022 /PRNewswire/ -- Wallaby Medical ("Wallaby" or the "Company"), a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, today announced that it has acquired phenox GmbH, including phenox's femtos GmbH ("femtos"), (together "phenox"), a German-based global innovation and technology leader in the...
Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility at Kansai International Airport
TOKYO, April, 21, 2022 /PRNewswire/ -- Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained IATA CEIV Pharma (*) pharmaceutical transport quality certification, effective April 5, for its temperature-controlled facility "NX-PHARMA Logistics Hub Kansai Airport" located inside the international cargo area of Kansai International Airport. Logo: https://kyodonewsprwire.jp/img/202204190123-O3-n3Z45H8m Nippon Express has been...
Initial Results from Novavax’ COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine
Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic Data from this combination trial will inform planned Phase 2 dose confirmation trial, scheduled to begin by the end of 2022 Immune response confirmed in stand-alone influenza vaccine and combination vaccine with potential path forward...
REPROCELL Signs Agreement to Prospectively Collect Samples for IFF’s Microbiome Study
BELTSVILLE, Md., April 20, 2022 /PRNewswire/ -- REPROCELL and IFF have entered into a clinical services agreement where in, REPROCELL will provide various types of samples for the study titled "Isolation and Characterization of Multiple Microbial Species from Diverse Healthy Adults (IsoMic)". The participants in the study will include donors of various...
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise. JENA, Germany and DUBLIN, Ireland, April 20, 2022 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has cleared the QUATERA® 700*, a revolution in phaco technology. It includes the ZEISS patented QUATTRO Pump® which delivers...
JW Therapeutics Announces IND Approval for the Clinical Trial of Carteyva® in Pediatric and Young Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
SHANGHAI, April 20, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced the Investigational New Drug (IND) clearance from the National Medical Products Administration (NMPA) of China for the study of the anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product Carteyva® (relmacabtagene autoleucel injection) in...
Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on April 27 at 10:00 CEST
STOCKHOLM, April 20, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presentation of the interim report for the period January - March 2022, which will be held on April 27 at 10:00 CEST,...
SoftBank Robotics Group Makes Strategic Equity Investment in Avalon SteriTech
Strive to Empower Public Health with Disinfection Robotics Solution in Post-Pandemic Era HONG KONG, April 20, 2022 /PRNewswire/ -- SoftBank Robotics Group Corp. ("SBRG") today announced its strategic equity investment in Avalon SteriTech ("Avalon"), marks a great step forward in strengthening the companies' collaboration since its joint venture was established in March 2021. Upon the completion of the transaction,...
